As of 2025-05-23, the Fair Value of Aldeyra Therapeutics Inc (ALDX) is -4.66 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.25 USD, the upside of Aldeyra Therapeutics Inc is -307.20%.
With the market price of 2.25 USD and our fair value calculation, Aldeyra Therapeutics Inc (ALDX) is not a good investment. Investing in ALDX stocks now will result in a potential loss of 307.20%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -37.55 | -57.78 | -62.02 | -37.54 | -55.85 | -50.15 |
| YoY growth | 38.27% | -53.87% | -7.34% | 39.47% | -48.77% | -6.45% |
| Market Cap (mil) | 134.78 |
| P/E | |
| Forward P/E |
| EPS | -0.93 |
| Avg earnings growth rate | -6.45% |
| TTM earnings | -55.85 |